Article

In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC*-Au-SCSNMe(2) and NHC*-Au-S-GLUC against advanced prostate cancer PC3.
Walther, W. ORCID: https://orcid.org/0000-0003-2884-0231, Althagafi, D., Curran, D., O'Beirne, C., Mc Carthy, C., Ott, I., Basu, U., Büttner, B., Sterner-Kock, A., Müller-Bunz, H., Sánchez-Sanz, G., Zhu, X. and Tacke, M.
Anti-Cancer Drugs 31 (7): 672-683. August 2020

Sorafenib, but not sunitinib, induces regulatory T cells in the peripheral blood of patients with metastatic renal cell carcinoma.
Floercken, A., Takvorian, A., Van Lessen, A., Singh, A., Hopfenmueller, W., Doerken, B. ORCID: https://orcid.org/0000-0001-7991-3643, Pezzutto, A. ORCID: https://orcid.org/0000-0002-3246-4470 and Westermann, J.
Anti-Cancer Drugs 23 (3): 298-302. March 2012

HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells.
Wegener, D., Deubzer, H.E. ORCID: https://orcid.org/0000-0002-6115-4893, Oehme, I., Milde, T., Hildmann, C., Schwienhorst, A. and Witt, O.
Anti-Cancer Drugs 19 (9): 849-857. October 2008

Anti-tumor activity of Titanocene Y in xenografted Caki-1 tumors in mice.
Fichtner, I., Pampillon, C., Sweeney, N.J., Strohfeldt, K. and Tacke, M.
Anti-Cancer Drugs 17 (3): 333-336. March 2006

Reduction of tamoxifen resistance in human breast carcinomas by tamoxifen-containing liposomes in vivo.
Zeisig, R., Rueckerl, D. and Fichtner, I.
Anti-Cancer Drugs 15 (7): 707-714. 1 August 2004

Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II study.
Thuss-Patience, P.C., von Minckwitz, G., Kretzschmar, A., Loibl, S., Schaller, G., Doerken, B. ORCID: https://orcid.org/0000-0001-7991-3643 and Reichardt, P.
Anti-Cancer Drugs 14 (7): 549-553. 1 August 2003

Effects of amifostine (WR-2721, ethyol) on tumor growth and pharmacology of cytotoxic drugs in human xenotransplanted neuroblastomas.
Fichtner, I., Lemm, M., Becker, M. and Berthold, F.
Anti-Cancer Drugs 8 : 174-181. 1 January 1997

Antineoplastic activity in vitro of free and liposomal alkylphosphocholines.
Zeisig, R., Jungmann, S., Arndt, D., Schuett, A. and Nissen, E.
Anti-Cancer Drugs 4 : 57-64. 1 January 1993

Pharmacokinetic behavior of 57CO-Bleomycin liposomes in mice: comparison with the unencapsulated substance.
Fichtner, I., Arndt, D., Reszka, R. and Gens, J.
Anti-Cancer Drugs 2 : 555-563. 1 January 1991

Antitumor effects of alkylphosphocholines in different murine tumor models, use of liposomal preparations.
Zeisig, R., Fichtner, I., Arndt, D. and Jungmann, S.
Anti-Cancer Drugs 2 : 411-417. 1 January 1991